Transport of Lipoprotein Lipase by Heparan Sulfate Proteoglycans
Transport of Lipoprotein Lipase by Heparan Sulfate Proteoglycans
批准号:
8136674
负责人:
Jon C. Gonzales
金额:
$3.1万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2012-09-14
关键词:
AdipocytesAtherosclerosisBasement membraneBindingBiological AssayBlood CirculationCardiacCardiac MyocytesCardiovascular DiseasesCause of DeathCellsCoculture TechniquesCore ProteinEndothelial CellsEndotheliumEnzymesHeparan Sulfate BiosynthesisHeparan Sulfate ProteoglycanHeparitin SulfateHydrolysisHypertriglyceridemiaImmune SeraImpairmentIn SituLeadLipoproteinsMeasuresMusMuscle FibersMutant Strains MiceMutationPeripheralPlasmaProteoglycanRoleSideSiteSmall Interfering RNAStructureTestingTissuesTriglyceridesUnited StatesWestern Blottingin vivoinsightlipoprotein lipasemacrophageprotein expressionproteoglycan core proteinpublic health relevancetraffickingtranscytosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lipoprotein lipase is the critical enzyme responsible for the hydrolysis of triglyceride-rich lipoproteins in the peripheral circulation. Cells, such as cardiac and skeletal myocytes, macrophages, and adipocytes synthesize and secrete lipoprotein lipase. It then traverses the basement membrane separating these cells from the microvasculature in the tissue. The enzyme is transported across the endothelial cells to its site of action on the lumen of the endothelium. Evidence suggests that transport depends on lipoprotein lipase binding to heparan sulfate proteoglycans. However, these studies were done in aortic endothelial cells, which are not physiologically relevant, and the identification of the active heparan sulfate proteoglycans was not determined. We hypothesize that specific heparan sulfate proteoglycans drive the transport of lipoprotein lipase from the abluminal side of the endothelium to its site of action on the luminal side. We intend to test this hypothesis through three specific aims: First, we will identify the relevant cardiac endothelial cell heparan sulfate proteoglycans that interact with lipoprotein lipase. Next, we will test if lipoprotein lipase transport across cardiac endothelial cells depends on heparan sulfate proteoglycans. Finally, we will test if lipoprotein lipase utilizes heparan sulfate proteoglycans for transport in vivo using mice bearing mutations in heparan sulfate biosynthesis or proteoglycan core proteins.
PUBLIC HEALTH RELEVANCE: Cardiovascular disease is the leading cause of death in the United States. Impairments in the expression, transport, or function of lipoprotein lipase can lead to hypertriglyceridemia, atherosclerosis, and other cardiovascular diseases. These studies will better define the role of heparan sulfate proteoglycans In the trafficking of lipoprotein lipase and will provide insight into the consequences of impaired heparan sulfate proteoglycan- lipoprotein lipase interactions in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transport of Lipoprotein Lipase by Heparan Sulfate Proteoglycans
-
批准号:8008770
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2009
-
负责人:Jon C. Gonzales
-
依托单位:
海外基金